Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001214 · ClinicalTrials.gov registry record

Collection of Blood From Patients With Pancytopenia

A clinical trial of Pancytopenia, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
38
Enrollment target
1
Study location

NCT00001214 is a study of Pancytopenia that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 38 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001214, a study of Pancytopenia, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
38 participants
Enrollment target
1
Study location

Study Summary

Aplastic anemia is a condition in which the cells normally found in blood are greatly decreased. The normal levels of white blood cells, red blood cells, and platelets are much lower in patients with aplastic anemia. Because of these low levels of blood cells, patients with aplastic anemia have a variety of immune system abnormalities. However, low levels of blood cells make it difficult to collect specialized white blood cells (mononuclear cells) for research studies. This study was designed to collect lymphocytes from patients with low levels of all blood cells (pancytopenia) for use in research. Patients participating in the study will undergo a special procedure known as lymphapheresis. During lymphapheresis blood is taken from the patient in a manner similar to blood donation. The white blood cells are selectively removed by spinning (centrifugation), and the remaining red blood cells and platelets are placed back (re-infused) into the donor s blood stream. Patients participating in this study will not benefit directly from it. However, cells collected in this study may increase scientific knowledge and improve understanding and treatment for diseases like aplastic anemia.

Conditions Studied

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 1986-04-30
Est. Completion 2020-08-17

What the Registry Record Tells You About NCT00001214

The ClinicalTrials.gov registry entry for NCT00001214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pancytopenia appearing as the primary indexed condition, and to 0 interventions.

NCT00001214 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001214 about?

NCT00001214 is a clinical study titled "Collection of Blood From Patients With Pancytopenia". Aplastic anemia is a condition in which the cells normally found in blood are greatly decreased. The normal levels of white blood cells, red blood cells, and platelets are much lower in patients with aplastic anemia. Because of these low levels of blood cells, patients with aplastic anemia have a v...

What is the current status of trial NCT00001214?

This trial is currently completed. The enrollment target is 38 participants. The study started on 1986-04-30. Estimated completion is 2020-08-17.

What conditions does trial NCT00001214 study?

This clinical trial studies the following conditions: Pancytopenia.

Who is sponsoring clinical trial NCT00001214?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001214 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pancytopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.